FDA approves first generic version of EpiPen
From the article<p>> <i>Other epinephrine injectors have been approved before, but they struggled to gain market share against a brand that used lobbying and marketing to establish a virtual monopoly on the market.</i><p>This got me thinking that consumers are at fault as well. But then I read the following from the linked article[0].<p>> <i>“Their most brilliant maneuver, clearly, was giving them [EpiPens] away to schools and making it the thing that they could say, ‘Well, the nurse knows how to use it,’ ” said R. Adams Dudley, a pulmonologist at the University of California at San Francisco. “What are the parents afraid of? Their child will be away from them, and they won’t be there to use it. If they can say the school nurse knows how to use an EpiPen; she’s never seen an Adrenaclick ... It’s just a fear thing.”</i><p>With such (understandable) absolute risk averseness what is the way out?..<p>[0] <a href="https://www.washingtonpost.com/business/economy/2016/08/25/7f83728a-6aee-11e6-ba32-5a4bf5aad4fa_story.html" rel="nofollow">https://www.washingtonpost.com/business/economy/2016/08/25/7...</a>